1. Scaratti Ch, Leonardi M, Silvaggi F, et al. Mapping European Welfare Models: State of the Art. of Strategies for Professional Integration and Reintegration of Persons with Chronic Diseases. Int J Environ Res Public Health 2018; 15(4): 781–801.
2.
Health at a Glance: Europe 2020 State of health in the EU cycle [cited 14.04.2023]. Available from URL: https://www.oecd-ilibrary.org/docserver/9789264265592en.pdf?expires=1590314324&id=id&accname=guest&checksum=648349C2A614F180B8422DA0D4BC7FF2.
3.
Busse R, Blümel M, Scheller-Kreinsen D, et al. Tackling chronic disease in Europe. Strategies, interventions and challenges. World Health Organization; European Observatory on Health Systems and Policies; 2010. Available from URL: https://who-sandbox.squiz.cloud/__data/assets/pdf_file/0008/96632/E93736.pdf.
4.
Towards better prevention and management of chronic diseases. European Commission Public Health [cited 24.05.2023]. Available from URL: https://ec.europa.eu/health/newsletter/169/focus_newsletter_en.htm.
5.
Brennan P, Perola M, Ommen G-J, van, et al. Chronic disease research in Europe and the need for integrated population cohorts. Eur J Epidemiol 2017; 32: 741–749.
6.
Health and health care in 2018, 2019. Statistics Poland, Social Surveys Department, Statistical Office in Krakow.
7.
Kupcewicz E, Grochans E, Kadučáková, H, et al. Personalized Healthcare: The Importance of Patients’ Rights in Clinical Practice from the Perspective of Nursing Students in Poland, Spain and Slovakia – A Cross-Sectional Study. J Pers Med 2021; 11(3): 191, doi: 10.3390/jpm11030191.
8.
Karabatić S, Šajnić A, Pleština S, et al. Croatian National Cancer Patient Experience Survey. Int J Environ Res Public Health 2022; 19(14): 82–85, doi: 10.3390/ijerph19148285.
9.
Petite SE, Hess MW, Wachtel H. The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease. J Pharm Technol 2021; 37(2): 95–106, doi: 10.1177/8755122520937649.
10.
Wisell K, Sporrong SK. The Raison D’être for the Community Pharmacy and the Community Pharmacist in Sweden: A Qualitative Interview Study. Pharmacy (Basel) 2015; 4(1): 3.
11.
Raport PMR: Rynek suplementów diety w Polsce: wzrost o 3% w 2020 roku [cited 14.04.2023]. Available from URL: https://healthcaremarketexperts.com/aktualnosci/rynek-trendy/raport-pmr-rynek-suplementow-diety-w-polsce-wzrost-o-3-w-2020-roku/ (in Polish).
12.
Rynek suplementów diety w Polsce: wzrost o 3% w 2020 roku [cited 14.04.2023]. Available from URL: https://biznes.newseria.pl/biuro-prasowe/zdrowie/rynek-suplementow-diety-w,b1356392541 (in Polish).
13.
Grant WB, Lahore H, McDonnell S, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020; 2(4): 988.
14.
Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front Immunol 2020; 10(11): 1712.
15.
Dwyer JT, Coates PM, Smith MJ. Dietary Supplements: Regulatory Challenges and Research Resources. Nutrients 2018; 10(1): 41.
16.
Oketch-Rabah HA, Roe AL, Muldoon-Jacobs K, et al. Challenges and Opportunities for Improving the Safety Assessment of Botanical Dietary Supplements: A United States Pharmacopeia Perspective. Clin Pharmacol Ther 2018; 104(3): 426–429.
17.
Jiang T. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation. Int J Food Sci Nutr 2009; 60(4): 293–301.
18.
Costello RB, Coates P. In the midst of confusion lies opportunity: fostering quality science in dietary supplement research. J Am Coll Nutr 2009; 20(1): 21–25.
19.
Karny-Rahkovich O, Blatt A, Elbaz-Greener GA, et al. Dietary supplement consumption among cardiac patients admitted to internal medicine and cardiac wards. Cardiol J 2015; 22(5): 510–518.
20.
Goldstein LH, Elias M, Ron-Avraham G, et al. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol 2007; 64(3): 373–380.
21.
Levy I, Attias S, Ben-Arye E, et al. Adverse events associated with interactions with dietary and herbal supplements among inpatients. Br J Clin Pharmacol 2017; 83(4): 836–845.
22.
Yeong SW, Choong YC. Knowledge and characteristics of herbal supplement usage among community pharmacy customers in a Malaysian population. Complement Ther Med 2017; 35, 92–108.
23.
Wawryk-Gawda E, Budzyńska B, Lis-Sochacka M, et al. Dietary supplements – consumer assessment based on questionnaire survey. Przegl Epidemiol 2018; 72(1): 111–120.
24.
Dickinson A, Blatman J, El-Dash N, et al. Consumer usage and reasons for using dietary supplements: report of a series of surveys. J Am Coll Nutr 2014; 33(2): 176–182.
25.
Dickinson A, MacKay D. Health habits and other characteristics of dietary supplement users: a review. Nutr J 2014; 13: 14.
26.
Kemper KJ, Amata-Kynvi A, Dvorkin L, et al. Herbs and other dietary supplements: healthcare professionals’ knowledge, attitudes, and practices. Altern Ther Health Med 2003; 9(3): 42–49.
27.
Kemper KJ, Gardiner P, Gobble J, et al. Expertise about herbs and dietary supplements among diverse health professionals. BMC Complement Altern Med 2006; 6: 15.
28.
Molen T, van der, Boven JF, van, Maguire T, et al. Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist. Br J Clin Pharmacol 2017; 83(1): 192–201, doi: 10.1111/bcp.13087.
29.
Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol 2014; 77: 756–766.